The Board denied service connection for monoclonal gammopathy of undetermined significance, finding that the evidence does not support a link to in-service exposure or injury.
The deciding factor: The evidence did not persuasively show that the Veteran's monoclonal gammopathy of undetermined significance began during active service or is otherwise related to an in-service injury or disease, including toxic exposure risk activity (TERA).
- Claimed conditions
- monoclonal gammopathy of undetermined significance
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- March 24, 2025
- Citation
- A25027167
Veterans Law Judge
Decisions by this judge: 2,188 · Granted: 23% (granted or partly granted, in the indexed decisions on this site)
Judge attribution: 2025 complete; earlier years partial.
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation A25027167.
What this means for you
A final Board denial may be appealed to the U.S. Court of Appeals for Veterans Claims, generally within 120 days of the Board mailing date. A Supplemental Claim with new and relevant evidence is a separate option. Another Higher-Level Review of the Board decision is not available. Check your own notice: this historical decision does not set your deadline.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Remanded (sent back)
The Board remands the claim for further evidentiary development to confirm the Veteran's status under the Blue Water Navy Act and ensure compliance with the duty to assist.
- Whole decision: Partly granted
The veteran's claim for a higher rating for monoclonal gammopathy of undetermined significance (MGUS) was denied. The claim for service connection for sarcoidosis was remanded for further evaluation.
- Whole decision: Granted
The Veteran's service connection for monoclonal gammopathy of undetermined significance is granted due to exposure to herbicide agents during his service in the Republic of Vietnam, as provided by the PACT Act.
- Whole decision: Remanded (sent back)
The Veteran's diabetes mellitus is rated at 20 percent. The Board finds a 40 percent rating is warranted for his diabetes mellitus as he requires insulin, restricted diet, and regulation of activities.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.